Complementary Stimulation of Hepatobiliary Transport and Detoxification Systems by Rifampicin and Ursodeoxycholic Acid in Humans
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,379
Bile salt transporters: molecular characterization, function, and regulation
Trauner, M., & Boyer, J. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00027.2002 · Cited by 999
Self-citationAn essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids
Xie, W., Radominska-Pandya, A., Shi, Y., Simon, C. M., Nelson, M. C., Ong, E. S., Waxman, D. J., & Evans, R. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051014398 · Cited by 757
Poupon, R., Lindor, K., Cauch-Dudek, K., Dickson, E., Poupon, R., & Heathcote, E. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70183-5 · Cited by 648
Stieger, B., Fattinger, K., Madon, J., Kullak-Ublick, G. A., & Meier, P. J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70224-1 · Cited by 582
Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms
Chiang, J. Y. L. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.11.006 · Cited by 546
Fickert, P., Fuchsbichler, A., Wagner, M., Zollner, G., Kaser, A., Tilg, H., Krause, R., Lammert, F., Langner, C., Zatloukal, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.009 · Cited by 468
Self-citationZollner, G. (2001) · Hepatology · doi:10.1053/jhep.2001.22646 · Cited by 362
Self-citationByrne, J. A., Strautnieks, S. S., Mieli–Vergani, G., Higgins, C. F., Linton, K. J., & Thompson, R. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36591 · Cited by 337
Schuetz, E. G., Strom, S., Yasuda, K., Lecureur, V., Assem, M., Brimer, C., Lamba, J., Kim, R. B., Ramachandran, V., Komoroski, B. J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106340200 · Cited by 334
Goulis, J., Leandro, G., & Burroughs, A. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11293-x · Cited by 315
Fickert, P., Zollner, G., Fuchsbichler, A., Stumptner, C., Weiglein, A. H., Lammert, F., Marschall, H., Tsybrovskyy, O., Zatloukal, K., Denk, H., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.35948 · Cited by 313
Self-citationThe Effect of Rifampin Treatment on Intestinal Expression of Human MRP Transporters
Fromm, M. F., Kauffmann, H.-M., Fritz, P., Burk, O., Kroemer, H. K., Warzok, R. W., Eichelbaum, M., Siegmund, W., & Schrenk, D. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64794-3 · Cited by 277
Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis
Zollner, G., Fickert, P., Silbert, D., Fuchsbichler, A., Marschall, H.-U., Zatloukal, K., Denk, H., & Trauner, M. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00096-5 · Cited by 275
Self-citationTreatment of pruritus of primary biliary cirrhosis with rifampin
Podesta, A., Lopez, P., Terg, R., Villamil, F., Flores, D., Mastai, R., Udaondo, C. B., & Companc, J. P. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01300759 · Cited by 267
Wagner, M., Fickert, P., Zollner, G., Fuchsbichler, A., Silbert, D., Tsybrovskyy, O., Zatloukal, K., Guo, G. L., Schuetz, J. D., Gonzalez, F. J., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01068-0 · Cited by 264
Self-citationCharacterization of Drug Transport by the Human Multidrug Resistance Protein 3 (ABCC3)
Zelcer, N., Saeki, T., Reid, G., Beijnen, J. H., & Borst, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107041200 · Cited by 258
Treatment of pruritus in primary biliary cirrhosis with rifampin
Ghent, C. N., & Carruthers, S. G. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90442-8 · Cited by 257
Fickert, P., Zollner, G., Fuchsbichler, A., Stumptner, C., Pojer, C., Zenz, R., Lammert, F., Stieger, B., Meier, P. J., Zatloukal, K., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.25542 · Cited by 257
Self-citationBeuers, U., Bilzer, M., Chittattu, A., Kullak-Ublick, G. A., Keppler, D., Paumgartner, G., & Dombrowski, F. (2001) · Hepatology · doi:10.1053/jhep.2001.24034 · Cited by 251
Northfield, T. C., & Hofmann, A. F. (1975) · Gut · doi:10.1136/gut.16.1.1 · Cited by 247
Antiepileptic Drugs Increase Plasma Levels of 4β-Hydroxycholesterolin Humans
Bodin, K., Bretillon, L., Aden, Y., Bertilsson, L., Broomé, U., Einarsson, C., & Diczfalusy, U. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105127200 · Cited by 241
Self-citationEffects of long-term rifampicin administration in primary biliary cirrhosis
Bachs, L., Parés, A., Elena, M., Piera, C., & Rodés, J. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90335-v · Cited by 235
COMPARISON OF RIFAMPICIN WITH PHENOBARBITONE FOR TREATMENT OF PRURITUS IN BILIARY CIRRHOSIS
Bachs, L., Elena, M., Parés, A., Piera, C., & Rodés, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91608-5 · Cited by 231
Bhalla, S., Ozalp, C., Fang, S., Xiang, L., & Kemper, J. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405423200 · Cited by 230
Li, T., & Chiang, J. Y. L. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00258.2004 · Cited by 218
Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease
Paumgartner, G., & Beuers, U. (2004) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00135-1 · Cited by 216
Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis
Prince, M. I., Burt, A. D., & Jones, D. E. J. (2002) · Gut · doi:10.1136/gut.50.3.436 · Cited by 202
Zollner, G., Fickert, P., Fuchsbichler, A., Silbert, D., Wagner, M., Arbeiter, S., Gonzalez, F. J., Marschall, H.-U., Zatloukal, K., Denk, H., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00228-9 · Cited by 193
Self-citationMetabolism of 4β-Hydroxycholesterol in Humans
Bodin, K., Andersson, U., Rystedt, E., Ellis, E., Norlin, M., Pikuleva, I., Eggertsen, G., Björkhem, I., & Diczfalusy, U. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201712200 · Cited by 179
Self-citationKurz, A. K., Graf, D., Schmitt, M., Vom Dahl, S., & Häussinger, D. (2001) · Gastroenterology · doi:10.1053/gast.2001.26262 · Cited by 168
Novel pathways of bile acid metabolism involving CYP3A4
Bodin, K., Lindbom, U., & Diczfalusy, U. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.11.003 · Cited by 141
Self-citationSevere Cholestasis Induced by Cholic Acid Feeding in Knockout Mice of Sister of P–Glycoprotein
Wang, R., Lam, P., Liu, L., Forrest, D., Yousef, I. M., Mignault, D., Phillips, J. M., & Ling, V. W. T. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.037 · Cited by 136
Almé, B., & Sjövall, J. (1980) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(80)90164-8 · Cited by 132
Axelson, M., Björkhem, I., Reihnér, E., & Einarsson, K. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80688-y · Cited by 119
Rifampin relieves pruritus in children with cholestatic liver disease
Cynamon, H. A., Andres, J. M., & Iafrate, R. P. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90027-x · Cited by 113
Use of Rifampin for Severe Pruritus in Children with Chronic Cholestasis
Yerushalmi, B., Sokol, R. J., Narkewicz, M. R., Smith, D., & Karrer, F. M. (1999) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.1999.tb02448.x · Cited by 104
Cançado, E. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00353-0 · Cited by 91
Marschall, H., MATERN, H., Wietholtz, H., Egestad, B., Matern, S., & Sjövall, J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115806 · Cited by 91
Self-citationStimulation of bile acid 6α-hydroxylation by rifampin
Wietholtz, H., Marschall, H., Sjövall, J., & Matern, S. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80268-6 · Cited by 81
Self-citationHoensch, H. P., Balzer, K., Dylewizc, P., Kirch, W., Goebell, H., & Ohnhaus, E. E. (1985) · European Journal of Clinical Pharmacology · doi:10.1007/bf00544371 · Cited by 76
Rifampicin-induced elevation of serum bile acids in man
Galeazzi, R. L., Lorenzini, I., & Orlandi, F. (1980) · Digestive Diseases and Sciences · doi:10.1007/bf01308307 · Cited by 63
Biliary Bile Acids in Primary Biliary Cirrhosis: Effect of Ursodeoxycholic Acid
Combes, B., Carithers, R. L., Maddrey, W. C., Muñoz, S. J., García–Tsao, G., Bonner, G. F., Boyer, J. L., Luketic, V. A., Shiffman, M. L., Peters, M. G., et al. (1999) · Hepatology · doi:10.1002/hep.510290618 · Cited by 58
Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the pastissues for the future
Poupon, R. E. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80232-9 · Cited by 56
Primary sclerosing cholangitis
Mendes, F. D., & Lindor, K. D. (2004) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00127-2 · Cited by 45
Influence of rifampin on serum markers of cholesterol and bile acid synthesis in men
Lütjohann, D., Hahn, C., Prange, W., Sudhop, T., Axelson, M., Sauerbruch, T., Bergmann, K. V., & Reichel, C. (2004) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp42307 · Cited by 39
Isoursodeoxycholic acid: metabolism and therapeutic effects in primary biliary cirrhosis
Marschall, H.-U., Broomé, U., Einarsson, C., Alvelius, G., Thomas, H. G., & Matern, S. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31635-7 · Cited by 37
Self-citation6α-Glucuronidation of hyodeoxycholic acid by human liver, kidney and small bowel microsomes
Marschall, H., MATERN, H., Egestad, B., Matern, S., & Sjövall, S. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90041-5 · Cited by 36
Self-citationEuverth, S., Angelin, B., Einarsson, K., NILSELL, K., & Björkhem, I. (1985) · Gastroenterology · doi:10.1016/s0016-5085(85)80144-x · Cited by 36
Rifampicin and treatment of cholestatic pruritus
Hofmann, A. F. (2002) · Gut · doi:10.1136/gut.51.5.756 · Cited by 28
Effects of rifampin on biliary lipids in humans
von Bergmann, K., Fierer, J., Mok, H. Y. I., & Grundy, S. M. (1981) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.19.2.342 · Cited by 8
Cited by
Dawson, P. A., Lan, T., & Rao, A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900012-jlr200 · Cited by 680
Intrahepatic cholestasis of pregnancy
Geenes, V., & Williamson, C. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.2049 · Cited by 675
New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond
Beuers, U., Trauner, M., Jansen, P., & Poupon, R. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.023 · Cited by 537
“In otherwise healthy gallstone patients, rifampicin induced upregulation of UGT1A1 and MRP2 facilitating bilirubin elimination and increased CYP3A4 expression facilitating detoxification of BAs [53].”
BackgroundSelf-citationMolecular physiology of bile acid signaling in health, disease, and aging
Perino, A., Demagny, H., Velazquez-Villegas, L., & Schoonjans, K. (2021) · Physiological Reviews · doi:10.1152/physrev.00049.2019 · Cited by 481
Intrahepatic Cholestasis of Pregnancy
Williamson, C., & Geenes, V. (2014) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000346 · Cited by 469
Metadata
- Authors
- MARSCHALL, H., WAGNER, M., ZOLLNER, G., FICKERT, P., DICZFALUSY, U., GUMHOLD, J., SILBERT, D., FUCHSBICHLER, A., BENTHIN, L., & GRUNDSTROM, R.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2005-08
- Volume
- 129
- Issue
- 2
- Pages
- 476-485
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W4237925152
- Cited by
- 325
- References
- 51
- FWCI
- 10.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.